Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Multistakeholder Perspective on Advancing Individualized Therapeutics

Clinical Pharmacology & Therapeutics(2023)10.1002/cpt.3030Source: DataRank Database

A Multistakeholder Perspective on Advancing Individualized Therapeutics is a research paper published in Clinical Pharmacology & Therapeutics (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.37)OA: bronzeTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Julia Vitarello,Insoo Hyun ORCID,Timothy W. Yu ORCID,Issam Zineh,Michael Pacanowski

Live enrichment

PubMed:37620252 PMC:PMC10592009 OpenAlex:https://openalex.org/W4386125812

NHGRI NIH HHS

Grant: R01 HG012247

Intramural FDA HHS

Grant: FD999999

FWCI

0.37

Citation Percentile

0.5%

Citation Trend

2024

2025

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3030

HYBRIDhttps://doi.org/10.1002/cpt.3030

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3030

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.3030

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37620252

Fields of Study

CRISPR and Genetic EngineeringCAR-T cell therapy researchBiomedical Ethics and RegulationMedicineHumansProspective StudiesPrecision MedicinePharmacogenetics

MeSH Terms

HumansPharmacogeneticsProspective StudiesPrecision Medicine

Keywords

Precision medicineModalitiesLimitingPersonalized medicineMedicineTherapeutic modalitiesDiseasePerspective (graphical)Intensive care medicineEngineering ethicsBioinformaticsComputer scienceInternal medicinePathologyEngineeringArtificial intelligenceBiology

Sustainable Development Goals

SDG 0: Partnerships for the goals